Clostridium difficile in faeces from healthy dogs and dogs with diarrhea

BackgroundThis study was conducted to evaluate the faecal occurrence and characterization of Clostridium difficile in clinically healthy dogs (N = 50) and in dogs with diarrhea (N = 20) in the Stockholm-Uppsala region of Sweden.FindingsClostridium difficile was isolated from 2/50 healthy dogs and from 2/20 diarrheic dogs. Isolates from healthy dogs were negative for toxin A and B and for the tcdA and tcdB genes. Both isolates from diarrheic dogs were positive for toxin B and for the tcdA and tcdB genes. The C. difficile isolates from healthy dogs had PCR ribotype 009 (SE-type 6) and 010 (SE-type 3) whereas both isolates from dogs with diarrhoea had the toxigenic ribotype 014 (SE-type 21). One of the isolates from healthy dogs was initially resistant to metronidazole.ConclusionsThis study revealed presence of toxigenic C. difficile in faecal samples of diarrheic dogs and low number of non- toxigenic isolates in healthy dogs from Uppsala-Stockholm region in Sweden. However, more comprehensive studies are warranted to investigate the role of C. difficile in gastrointestinal disease in dogs.

[1]  A. Weintraub,et al.  Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. , 2010, Anaerobe.

[2]  D. Musher,et al.  Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. , 2007, The Journal of antimicrobial chemotherapy.

[3]  K. Krovacek,et al.  Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea. , 2007, Comparative immunology, microbiology and infectious diseases.

[4]  J. Weese,et al.  Evaluation of Clostridium difficile in dogs and the household environment , 2009, Epidemiology and Infection.

[5]  T. Åkerlund,et al.  Epidemiology and Molecular Characterization of Clostridium difficile Strains from Patients with Diarrhea: Low Disease Incidence and Evidence of Limited Cross-Infection in a Swedish Teaching Hospital , 2003, Journal of Clinical Microbiology.

[6]  J. Brazier,et al.  PCR Targeted to the 16S-23S rRNA Gene Intergenic Spacer Region ofClostridium difficile and Construction of a Library Consisting of 116 Different PCR Ribotypes , 1999, Journal of Clinical Microbiology.

[7]  R. Carman,et al.  Clostridium difficile binary toxin (CDT) and diarrhea. , 2011, Anaerobe.

[8]  J. Weese,et al.  Incidence of acquisition of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and other health-care-associated pathogens by dogs that participate in animal-assisted interventions. , 2009, Journal of the American Veterinary Medical Association.

[9]  T. Peláez,et al.  Metronidazole Resistance in Clostridium difficile Is Heterogeneous , 2008, Journal of Clinical Microbiology.

[10]  M. Rupnik,et al.  Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates , 2012, BMC Microbiology.

[11]  P. Gumerlock,et al.  Fecal Shedding of Clostridium Difficile in Dogs: A Period Prevalence Survey in a Veterinary Medical Teaching Hospital , 1994, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[12]  S. Marks,et al.  Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs. , 2003, Veterinary microbiology.

[13]  S. Borriello,et al.  Household pets as a potential reservoir for Clostridium difficile infection. , 1983, Journal of clinical pathology.

[14]  M. Rupnik.  Clostridium difficile toxinotyping. , 2010, Methods in molecular biology.

[15]  J. Ballard,et al.  Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.